Last reviewed · How we verify
Oral Sildenafil 50 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Oral Sildenafil 50 mg (Oral Sildenafil 50 mg) — Strategic Science & Technologies, LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oral Sildenafil 50 mg TARGET | Oral Sildenafil 50 mg | Strategic Science & Technologies, LLC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oral Sildenafil 50 mg CI watch — RSS
- Oral Sildenafil 50 mg CI watch — Atom
- Oral Sildenafil 50 mg CI watch — JSON
- Oral Sildenafil 50 mg alone — RSS
Cite this brief
Drug Landscape (2026). Oral Sildenafil 50 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-sildenafil-50-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab